<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-31" modified="2024-10-02" version="163" xmlns="http://uniprot.org/uniprot">
  <accession>Q53EL6</accession>
  <accession>B2RCV4</accession>
  <accession>B5ME91</accession>
  <accession>O15501</accession>
  <accession>Q5VZS6</accession>
  <accession>Q6PJI5</accession>
  <accession>Q8TAR5</accession>
  <accession>Q99834</accession>
  <name>PDCD4_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Programmed cell death protein 4</fullName>
    </recommendedName>
    <alternativeName>
      <fullName>Neoplastic transformation inhibitor protein</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Nuclear antigen H731-like</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Protein 197/15a</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">PDCD4</name>
    <name type="synonym">H731</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1997" name="Res. Commun. Biochem. Cell Mol. Biol." volume="1" first="109" last="120">
      <title>Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle.</title>
      <authorList>
        <person name="Matsuhashi S."/>
        <person name="Yoshinaga H."/>
        <person name="Yatsuki H."/>
        <person name="Tsugita A."/>
        <person name="Hori K."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANT VAL-36</scope>
    <source>
      <tissue>Glial tumor</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1998" name="J. Immunol." volume="161" first="3493" last="3500">
      <title>Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.</title>
      <authorList>
        <person name="Azzoni L."/>
        <person name="Zatsepina O."/>
        <person name="Abebe B."/>
        <person name="Bennett I.M."/>
        <person name="Kanakaraj P."/>
        <person name="Perussia B."/>
      </authorList>
      <dbReference type="PubMed" id="9759869"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>INDUCTION</scope>
    <scope>VARIANT VAL-36</scope>
    <source>
      <tissue>Blood</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
    <scope>VARIANT VAL-36</scope>
  </reference>
  <reference key="4">
    <citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Totoki Y."/>
        <person name="Toyoda A."/>
        <person name="Takeda T."/>
        <person name="Sakaki Y."/>
        <person name="Tanaka A."/>
        <person name="Yokoyama S."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <scope>VARIANT VAL-36</scope>
    <source>
      <tissue>Spleen</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
      <title>The DNA sequence and comparative analysis of human chromosome 10.</title>
      <authorList>
        <person name="Deloukas P."/>
        <person name="Earthrowl M.E."/>
        <person name="Grafham D.V."/>
        <person name="Rubenfield M."/>
        <person name="French L."/>
        <person name="Steward C.A."/>
        <person name="Sims S.K."/>
        <person name="Jones M.C."/>
        <person name="Searle S."/>
        <person name="Scott C."/>
        <person name="Howe K."/>
        <person name="Hunt S.E."/>
        <person name="Andrews T.D."/>
        <person name="Gilbert J.G.R."/>
        <person name="Swarbreck D."/>
        <person name="Ashurst J.L."/>
        <person name="Taylor A."/>
        <person name="Battles J."/>
        <person name="Bird C.P."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Ashwell R.I.S."/>
        <person name="Ambrose K.D."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Bailey J."/>
        <person name="Banerjee R."/>
        <person name="Bates K."/>
        <person name="Beasley H."/>
        <person name="Bray-Allen S."/>
        <person name="Brown A.J."/>
        <person name="Brown J.Y."/>
        <person name="Burford D.C."/>
        <person name="Burrill W."/>
        <person name="Burton J."/>
        <person name="Cahill P."/>
        <person name="Camire D."/>
        <person name="Carter N.P."/>
        <person name="Chapman J.C."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C.M."/>
        <person name="Clegg S."/>
        <person name="Corby N."/>
        <person name="Coulson A."/>
        <person name="Dhami P."/>
        <person name="Dutta I."/>
        <person name="Dunn M."/>
        <person name="Faulkner L."/>
        <person name="Frankish A."/>
        <person name="Frankland J.A."/>
        <person name="Garner P."/>
        <person name="Garnett J."/>
        <person name="Gribble S."/>
        <person name="Griffiths C."/>
        <person name="Grocock R."/>
        <person name="Gustafson E."/>
        <person name="Hammond S."/>
        <person name="Harley J.L."/>
        <person name="Hart E."/>
        <person name="Heath P.D."/>
        <person name="Ho T.P."/>
        <person name="Hopkins B."/>
        <person name="Horne J."/>
        <person name="Howden P.J."/>
        <person name="Huckle E."/>
        <person name="Hynds C."/>
        <person name="Johnson C."/>
        <person name="Johnson D."/>
        <person name="Kana A."/>
        <person name="Kay M."/>
        <person name="Kimberley A.M."/>
        <person name="Kershaw J.K."/>
        <person name="Kokkinaki M."/>
        <person name="Laird G.K."/>
        <person name="Lawlor S."/>
        <person name="Lee H.M."/>
        <person name="Leongamornlert D.A."/>
        <person name="Laird G."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Loveland J."/>
        <person name="Lovell J."/>
        <person name="McLaren S."/>
        <person name="McLay K.E."/>
        <person name="McMurray A."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L."/>
        <person name="Milne S."/>
        <person name="Nickerson T."/>
        <person name="Nguyen M."/>
        <person name="Overton-Larty E."/>
        <person name="Palmer S.A."/>
        <person name="Pearce A.V."/>
        <person name="Peck A.I."/>
        <person name="Pelan S."/>
        <person name="Phillimore B."/>
        <person name="Porter K."/>
        <person name="Rice C.M."/>
        <person name="Rogosin A."/>
        <person name="Ross M.T."/>
        <person name="Sarafidou T."/>
        <person name="Sehra H.K."/>
        <person name="Shownkeen R."/>
        <person name="Skuce C.D."/>
        <person name="Smith M."/>
        <person name="Standring L."/>
        <person name="Sycamore N."/>
        <person name="Tester J."/>
        <person name="Thorpe A."/>
        <person name="Torcasso W."/>
        <person name="Tracey A."/>
        <person name="Tromans A."/>
        <person name="Tsolas J."/>
        <person name="Wall M."/>
        <person name="Walsh J."/>
        <person name="Wang H."/>
        <person name="Weinstock K."/>
        <person name="West A.P."/>
        <person name="Willey D.L."/>
        <person name="Whitehead S.L."/>
        <person name="Wilming L."/>
        <person name="Wray P.W."/>
        <person name="Young L."/>
        <person name="Chen Y."/>
        <person name="Lovering R.C."/>
        <person name="Moschonas N.K."/>
        <person name="Siebert R."/>
        <person name="Fechtel K."/>
        <person name="Bentley D."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Doucette-Stamm L."/>
        <person name="Beck S."/>
        <person name="Smith D.R."/>
        <person name="Rogers J."/>
      </authorList>
      <dbReference type="PubMed" id="15164054"/>
      <dbReference type="DOI" id="10.1038/nature02462"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <scope>VARIANTS VAL-36 AND TYR-48</scope>
    <source>
      <tissue>Brain</tissue>
      <tissue>Skin</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1999" name="Pathol. Int." volume="49" first="1067" last="1077">
      <title>Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody.</title>
      <authorList>
        <person name="Yoshinaga H."/>
        <person name="Matsuhashi S."/>
        <person name="Fujiyama C."/>
        <person name="Masaki Z."/>
      </authorList>
      <dbReference type="PubMed" id="10632927"/>
      <dbReference type="DOI" id="10.1046/j.1440-1827.1999.00995.x"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2003" name="J. Pathol." volume="200" first="640" last="646">
      <title>Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.</title>
      <authorList>
        <person name="Chen Y."/>
        <person name="Knosel T."/>
        <person name="Kristiansen G."/>
        <person name="Pietas A."/>
        <person name="Garber M.E."/>
        <person name="Matsuhashi S."/>
        <person name="Ozaki I."/>
        <person name="Petersen I."/>
      </authorList>
      <dbReference type="PubMed" id="12898601"/>
      <dbReference type="DOI" id="10.1002/path.1378"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
      <title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
      <authorList>
        <person name="Brill L.M."/>
        <person name="Salomon A.R."/>
        <person name="Ficarro S.B."/>
        <person name="Mukherji M."/>
        <person name="Stettler-Gill M."/>
        <person name="Peters E.C."/>
      </authorList>
      <dbReference type="PubMed" id="15144186"/>
      <dbReference type="DOI" id="10.1021/ac035352d"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2005" name="Cancer Res." volume="65" first="11282" last="11286">
      <title>Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.</title>
      <authorList>
        <person name="Palamarchuk A."/>
        <person name="Efanov A."/>
        <person name="Maximov V."/>
        <person name="Aqeilan R.I."/>
        <person name="Croce C.M."/>
        <person name="Pekarsky Y."/>
      </authorList>
      <dbReference type="PubMed" id="16357133"/>
      <dbReference type="DOI" id="10.1158/0008-5472.can-05-3469"/>
    </citation>
    <scope>PHOSPHORYLATION AT SER-67 AND SER-457 BY PKB</scope>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF SER-67 AND SER-457</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
      <title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
      <authorList>
        <person name="Rush J."/>
        <person name="Moritz A."/>
        <person name="Lee K.A."/>
        <person name="Guo A."/>
        <person name="Goss V.L."/>
        <person name="Spek E.J."/>
        <person name="Zhang H."/>
        <person name="Zha X.-M."/>
        <person name="Polakiewicz R.D."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="15592455"/>
      <dbReference type="DOI" id="10.1038/nbt1046"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-152</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1297" last="1306">
      <title>Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.</title>
      <authorList>
        <person name="Yang H.-S."/>
        <person name="Matthews C.P."/>
        <person name="Clair T."/>
        <person name="Wang Q."/>
        <person name="Baker A.R."/>
        <person name="Li C.-C."/>
        <person name="Tan T.-H."/>
        <person name="Colburn N.H."/>
      </authorList>
      <dbReference type="PubMed" id="16449643"/>
      <dbReference type="DOI" id="10.1128/mcb.26.4.1297-1306.2006"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
      <title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
      <authorList>
        <person name="Beausoleil S.A."/>
        <person name="Villen J."/>
        <person name="Gerber S.A."/>
        <person name="Rush J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="16964243"/>
      <dbReference type="DOI" id="10.1038/nbt1240"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2006" name="Science" volume="314" first="467" last="471">
      <title>S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.</title>
      <authorList>
        <person name="Dorrello N.V."/>
        <person name="Peschiaroli A."/>
        <person name="Guardavaccaro D."/>
        <person name="Colburn N.H."/>
        <person name="Sherman N.E."/>
        <person name="Pagano M."/>
      </authorList>
      <dbReference type="PubMed" id="17053147"/>
      <dbReference type="DOI" id="10.1126/science.1130276"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>PHOSPHORYLATION AT SER-67 BY RPS6KB1</scope>
    <scope>PHOSPHODEGRON MOTIF</scope>
    <scope>INTERACTION WITH BTRC AND FBXW11</scope>
    <scope>UBIQUITINATION</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>MUTAGENESIS OF SER-67; SER-71 AND SER-76</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-80 AND SER-94</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-94 AND SER-457</scope>
    <scope>VARIANT [LARGE SCALE ANALYSIS] VAL-36</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-76; SER-78; SER-313; SER-317 AND SER-457</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-68; SER-71; SER-76; SER-78; SER-313 AND SER-317</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="24">
    <citation type="submission" date="2007-04" db="PDB data bank">
      <title>Solution structure of the MA3 domain of human programmed cell death 4.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 320-450</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3274" last="3279">
      <title>PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains.</title>
      <authorList>
        <person name="Suzuki C."/>
        <person name="Garces R.G."/>
        <person name="Edmonds K.A."/>
        <person name="Hiller S."/>
        <person name="Hyberts S.G."/>
        <person name="Marintchev A."/>
        <person name="Wagner G."/>
      </authorList>
      <dbReference type="PubMed" id="18296639"/>
      <dbReference type="DOI" id="10.1073/pnas.0712235105"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 157-320</scope>
    <scope>FUNCTION</scope>
    <scope>DOMAIN</scope>
    <scope>INTERACTION WITH EIF4A</scope>
    <scope>SUBUNIT</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2009" name="EMBO J." volume="28" first="274" last="285">
      <title>Structural basis for translational inhibition by the tumour suppressor Pdcd4.</title>
      <authorList>
        <person name="Loh P.G."/>
        <person name="Yang H.S."/>
        <person name="Walsh M.A."/>
        <person name="Wang Q."/>
        <person name="Wang X."/>
        <person name="Cheng Z."/>
        <person name="Liu D."/>
        <person name="Song H."/>
      </authorList>
      <dbReference type="PubMed" id="19153607"/>
      <dbReference type="DOI" id="10.1038/emboj.2008.278"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 157-469</scope>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH EIF4A1 AND EIF4G</scope>
    <scope>SUBUNIT</scope>
    <scope>MUTAGENESIS OF GLU-174; GLU-210; GLU-249; LEU-252; ASP-253; PRO-255; HIS-358; ASP-414; ASP-418 AND PRO-420</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="3148" last="3153">
      <title>Crystal structure of the eIF4A-PDCD4 complex.</title>
      <authorList>
        <person name="Chang J.H."/>
        <person name="Cho Y.H."/>
        <person name="Sohn S.Y."/>
        <person name="Choi J.M."/>
        <person name="Kim A."/>
        <person name="Kim Y.C."/>
        <person name="Jang S.K."/>
        <person name="Cho Y."/>
      </authorList>
      <dbReference type="PubMed" id="19204291"/>
      <dbReference type="DOI" id="10.1073/pnas.0808275106"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 163-469 IN COMPLEX WITH EIF4A1</scope>
    <scope>FUNCTION</scope>
    <scope>SUBUNIT</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF ASP-253; MET-333; GLU-337; LEU-340; PHE-359 AND HIS-361</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
      <title>The consensus coding sequences of human breast and colorectal cancers.</title>
      <authorList>
        <person name="Sjoeblom T."/>
        <person name="Jones S."/>
        <person name="Wood L.D."/>
        <person name="Parsons D.W."/>
        <person name="Lin J."/>
        <person name="Barber T.D."/>
        <person name="Mandelker D."/>
        <person name="Leary R.J."/>
        <person name="Ptak J."/>
        <person name="Silliman N."/>
        <person name="Szabo S."/>
        <person name="Buckhaults P."/>
        <person name="Farrell C."/>
        <person name="Meeh P."/>
        <person name="Markowitz S.D."/>
        <person name="Willis J."/>
        <person name="Dawson D."/>
        <person name="Willson J.K.V."/>
        <person name="Gazdar A.F."/>
        <person name="Hartigan J."/>
        <person name="Wu L."/>
        <person name="Liu C."/>
        <person name="Parmigiani G."/>
        <person name="Park B.H."/>
        <person name="Bachman K.E."/>
        <person name="Papadopoulos N."/>
        <person name="Vogelstein B."/>
        <person name="Kinzler K.W."/>
        <person name="Velculescu V.E."/>
      </authorList>
      <dbReference type="PubMed" id="16959974"/>
      <dbReference type="DOI" id="10.1126/science.1133427"/>
    </citation>
    <scope>VARIANT [LARGE SCALE ANALYSIS] ARG-120</scope>
  </reference>
  <comment type="function">
    <text evidence="1 11 12 14 15 16 17">Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity).</text>
  </comment>
  <comment type="subunit">
    <text evidence="1 14 15 16 17">Interacts (via MI domains) with EIF4A2 (By similarity). Interacts (via MI domains) with EIF4A1 (via N-terminal domain). Heterotrimer with EIF4A1; one molecule of PDCD4 binds two molecules of EIF4A1. Interacts with EIF4G1. May form a complex with EIF4A1 and EIF4G1. The interaction between PDCD4 and EIF4A1 interferes with the interaction between EIF4A1 and EIF4G. When phosphorylated, interacts with BTRC and FBXW11.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-1222467">
      <id>P02649</id>
      <label>APOE</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-73449">
      <id>P60842</id>
      <label>EIF4A1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>10</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-73473">
      <id>Q14240</id>
      <label>EIF4A2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-10232522">
      <id>Q14240-2</id>
      <label>EIF4A2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-299104">
      <id>P38919</id>
      <label>EIF4A3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-2010251">
      <id>P49810</id>
      <label>PSEN2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-73886">
      <id>Q04206</id>
      <label>RELA</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-935824">
      <id>Q53EL6</id>
    </interactant>
    <interactant intactId="EBI-351850">
      <id>P62277</id>
      <label>RPS13</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="2">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="2">Cytoplasm</location>
    </subcellularLocation>
    <text evidence="11">Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133).</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q53EL6-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q53EL6-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_045622"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="7 8 12">Up-regulated in proliferative cells. Highly expressed in epithelial cells of the mammary gland. Reduced expression in lung cancer and colon carcinoma.</text>
  </comment>
  <comment type="induction">
    <text evidence="18">IL2/interleukin-2 stimulation inhibits expression, while IL12/interleukin-12 increases expression.</text>
  </comment>
  <comment type="domain">
    <text evidence="15 17">Binds EIF4A1 via both MI domains.</text>
  </comment>
  <comment type="PTM">
    <text evidence="14">Polyubiquitinated, leading to its proteasomal degradation. Rapidly degraded in response to mitogens. Phosphorylation of the phosphodegron promotes interaction with BTRC and proteasomal degradation.</text>
  </comment>
  <comment type="PTM">
    <text evidence="11 14">Phosphorylated at Ser-67 by RPS6KB1 in response to mitogens; phosphorylation promotes proteasomal degradation of PDCD4.</text>
  </comment>
  <comment type="similarity">
    <text evidence="22">Belongs to the PDCD4 family.</text>
  </comment>
  <comment type="sequence caution" evidence="22">
    <conflict type="erroneous gene model prediction">
      <sequence resource="EMBL-CDS" id="AAB42218" version="1"/>
    </conflict>
  </comment>
  <comment type="sequence caution" evidence="22">
    <conflict type="miscellaneous discrepancy">
      <sequence resource="EMBL-CDS" id="AAH15036" version="1"/>
    </conflict>
    <text>Contaminating sequence. Potential poly-A sequence.</text>
  </comment>
  <comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
    <link uri="https://atlasgeneticsoncology.org/gene/41675/PDCD4"/>
  </comment>
  <dbReference type="EMBL" id="U83908">
    <property type="protein sequence ID" value="AAB42218.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U96628">
    <property type="protein sequence ID" value="AAB67706.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK315295">
    <property type="protein sequence ID" value="BAG37701.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK223623">
    <property type="protein sequence ID" value="BAD97343.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL158163">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL136368">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC015036">
    <property type="protein sequence ID" value="AAH15036.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC026104">
    <property type="protein sequence ID" value="AAH26104.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC031049">
    <property type="protein sequence ID" value="AAH31049.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS44478.1">
    <molecule id="Q53EL6-2"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS7567.1">
    <molecule id="Q53EL6-1"/>
  </dbReference>
  <dbReference type="PIR" id="JC5193">
    <property type="entry name" value="JC5193"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_055271.2">
    <molecule id="Q53EL6-1"/>
    <property type="nucleotide sequence ID" value="NM_014456.4"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_663314.1">
    <molecule id="Q53EL6-2"/>
    <property type="nucleotide sequence ID" value="NM_145341.3"/>
  </dbReference>
  <dbReference type="PDB" id="2GGF">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=327-450"/>
  </dbReference>
  <dbReference type="PDB" id="2KZT">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=157-318"/>
  </dbReference>
  <dbReference type="PDB" id="2RG8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.80 A"/>
    <property type="chains" value="A/B=157-320"/>
  </dbReference>
  <dbReference type="PDB" id="2ZU6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="B/E=163-469"/>
  </dbReference>
  <dbReference type="PDB" id="3EIJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B=157-469"/>
  </dbReference>
  <dbReference type="PDB" id="8XXL">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="CD=1-469"/>
  </dbReference>
  <dbReference type="PDB" id="8XXM">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="CD=1-469"/>
  </dbReference>
  <dbReference type="PDB" id="8XXN">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="CD=1-469"/>
  </dbReference>
  <dbReference type="PDBsum" id="2GGF"/>
  <dbReference type="PDBsum" id="2KZT"/>
  <dbReference type="PDBsum" id="2RG8"/>
  <dbReference type="PDBsum" id="2ZU6"/>
  <dbReference type="PDBsum" id="3EIJ"/>
  <dbReference type="PDBsum" id="8XXL"/>
  <dbReference type="PDBsum" id="8XXM"/>
  <dbReference type="PDBsum" id="8XXN"/>
  <dbReference type="AlphaFoldDB" id="Q53EL6"/>
  <dbReference type="BMRB" id="Q53EL6"/>
  <dbReference type="EMDB" id="EMD-38752"/>
  <dbReference type="EMDB" id="EMD-38753"/>
  <dbReference type="EMDB" id="EMD-38754"/>
  <dbReference type="SMR" id="Q53EL6"/>
  <dbReference type="BioGRID" id="118098">
    <property type="interactions" value="179"/>
  </dbReference>
  <dbReference type="CORUM" id="Q53EL6"/>
  <dbReference type="DIP" id="DIP-29756N"/>
  <dbReference type="ELM" id="Q53EL6"/>
  <dbReference type="IntAct" id="Q53EL6">
    <property type="interactions" value="59"/>
  </dbReference>
  <dbReference type="MINT" id="Q53EL6"/>
  <dbReference type="STRING" id="9606.ENSP00000280154"/>
  <dbReference type="BindingDB" id="Q53EL6"/>
  <dbReference type="ChEMBL" id="CHEMBL1781868"/>
  <dbReference type="DrugCentral" id="Q53EL6"/>
  <dbReference type="CarbonylDB" id="Q53EL6"/>
  <dbReference type="GlyGen" id="Q53EL6">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q53EL6"/>
  <dbReference type="MetOSite" id="Q53EL6"/>
  <dbReference type="PhosphoSitePlus" id="Q53EL6"/>
  <dbReference type="SwissPalm" id="Q53EL6"/>
  <dbReference type="BioMuta" id="PDCD4"/>
  <dbReference type="DMDM" id="317373317"/>
  <dbReference type="jPOST" id="Q53EL6"/>
  <dbReference type="MassIVE" id="Q53EL6"/>
  <dbReference type="PaxDb" id="9606-ENSP00000280154"/>
  <dbReference type="PeptideAtlas" id="Q53EL6"/>
  <dbReference type="ProteomicsDB" id="6218"/>
  <dbReference type="ProteomicsDB" id="62437">
    <molecule id="Q53EL6-1"/>
  </dbReference>
  <dbReference type="Pumba" id="Q53EL6"/>
  <dbReference type="Antibodypedia" id="616">
    <property type="antibodies" value="995 antibodies from 43 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="27250"/>
  <dbReference type="Ensembl" id="ENST00000280154.12">
    <molecule id="Q53EL6-1"/>
    <property type="protein sequence ID" value="ENSP00000280154.7"/>
    <property type="gene ID" value="ENSG00000150593.18"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000393104.6">
    <molecule id="Q53EL6-2"/>
    <property type="protein sequence ID" value="ENSP00000376816.2"/>
    <property type="gene ID" value="ENSG00000150593.18"/>
  </dbReference>
  <dbReference type="GeneID" id="27250"/>
  <dbReference type="KEGG" id="hsa:27250"/>
  <dbReference type="MANE-Select" id="ENST00000280154.12">
    <property type="protein sequence ID" value="ENSP00000280154.7"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_014456.5"/>
    <property type="RefSeq protein sequence ID" value="NP_055271.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001kzg.4">
    <molecule id="Q53EL6-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:8763"/>
  <dbReference type="CTD" id="27250"/>
  <dbReference type="DisGeNET" id="27250"/>
  <dbReference type="GeneCards" id="PDCD4"/>
  <dbReference type="HGNC" id="HGNC:8763">
    <property type="gene designation" value="PDCD4"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000150593">
    <property type="expression patterns" value="Tissue enhanced (pancreas)"/>
  </dbReference>
  <dbReference type="MIM" id="608610">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q53EL6"/>
  <dbReference type="OpenTargets" id="ENSG00000150593"/>
  <dbReference type="PharmGKB" id="PA33113"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000150593"/>
  <dbReference type="eggNOG" id="KOG0403">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00390000015948"/>
  <dbReference type="HOGENOM" id="CLU_025354_1_0_1"/>
  <dbReference type="InParanoid" id="Q53EL6"/>
  <dbReference type="OMA" id="GMEQGFI"/>
  <dbReference type="OrthoDB" id="1217702at2759"/>
  <dbReference type="PhylomeDB" id="Q53EL6"/>
  <dbReference type="TreeFam" id="TF323207"/>
  <dbReference type="PathwayCommons" id="Q53EL6"/>
  <dbReference type="Reactome" id="R-HSA-8950505">
    <property type="pathway name" value="Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q53EL6"/>
  <dbReference type="SIGNOR" id="Q53EL6"/>
  <dbReference type="BioGRID-ORCS" id="27250">
    <property type="hits" value="11 hits in 1162 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="PDCD4">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q53EL6"/>
  <dbReference type="GeneWiki" id="PDCD4"/>
  <dbReference type="GenomeRNAi" id="27250"/>
  <dbReference type="Pharos" id="Q53EL6">
    <property type="development level" value="Tchem"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q53EL6"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 10"/>
  </dbReference>
  <dbReference type="RNAct" id="Q53EL6">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000150593">
    <property type="expression patterns" value="Expressed in body of pancreas and 207 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q53EL6">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006915">
    <property type="term" value="P:apoptotic process"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030509">
    <property type="term" value="P:BMP signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071222">
    <property type="term" value="P:cellular response to lipopolysaccharide"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060940">
    <property type="term" value="P:epithelial to mesenchymal transition involved in cardiac fibroblast development"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043066">
    <property type="term" value="P:negative regulation of apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900016">
    <property type="term" value="P:negative regulation of cytokine production involved in inflammatory response"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045892">
    <property type="term" value="P:negative regulation of DNA-templated transcription"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043508">
    <property type="term" value="P:negative regulation of JUN kinase activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904761">
    <property type="term" value="P:negative regulation of myofibroblast differentiation"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1905064">
    <property type="term" value="P:negative regulation of vascular associated smooth muscle cell differentiation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904706">
    <property type="term" value="P:negative regulation of vascular associated smooth muscle cell proliferation"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:2000353">
    <property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050729">
    <property type="term" value="P:positive regulation of inflammatory response"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1901224">
    <property type="term" value="P:positive regulation of non-canonical NF-kappaB signal transduction"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1905461">
    <property type="term" value="P:positive regulation of vascular associated smooth muscle cell apoptotic process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043279">
    <property type="term" value="P:response to alkaloid"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009725">
    <property type="term" value="P:response to hormone"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.25.40.180">
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="IDEAL" id="IID00729"/>
  <dbReference type="InterPro" id="IPR016024">
    <property type="entry name" value="ARM-type_fold"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR003891">
    <property type="entry name" value="Initiation_fac_eIF4g_MI"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR039778">
    <property type="entry name" value="PDCD4"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12626">
    <property type="entry name" value="PROGRAMMED CELL DEATH 4"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR12626:SF3">
    <property type="entry name" value="PROGRAMMED CELL DEATH PROTEIN 4"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02847">
    <property type="entry name" value="MA3"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SMART" id="SM00544">
    <property type="entry name" value="MA3"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF48371">
    <property type="entry name" value="ARM repeat"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51366">
    <property type="entry name" value="MI"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0053">Apoptosis</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0043">Tumor suppressor</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="chain" id="PRO_0000256519" description="Programmed cell death protein 4">
    <location>
      <begin position="1"/>
      <end position="469"/>
    </location>
  </feature>
  <feature type="domain" description="MI 1" evidence="5">
    <location>
      <begin position="163"/>
      <end position="284"/>
    </location>
  </feature>
  <feature type="domain" description="MI 2" evidence="5">
    <location>
      <begin position="326"/>
      <end position="449"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="6">
    <location>
      <begin position="1"/>
      <end position="38"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="6">
    <location>
      <begin position="58"/>
      <end position="128"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="4">
    <location>
      <begin position="58"/>
      <end position="64"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Phosphodegron">
    <location>
      <begin position="70"/>
      <end position="76"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="4">
    <location>
      <begin position="241"/>
      <end position="250"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="6">
    <location>
      <begin position="11"/>
      <end position="27"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="6">
    <location>
      <begin position="73"/>
      <end position="89"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylmethionine" evidence="28">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="3">
    <location>
      <position position="25"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by PKB and RPS6KB1" evidence="11 14 31">
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="31">
    <location>
      <position position="68"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="30 31">
    <location>
      <position position="71"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="27 28 30 31">
    <location>
      <position position="76"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="27 28 30 31">
    <location>
      <position position="78"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="27">
    <location>
      <position position="80"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="27 28">
    <location>
      <position position="94"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine" evidence="24">
    <location>
      <position position="152"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="30 31">
    <location>
      <position position="313"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="30 31">
    <location>
      <position position="317"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by PKB" evidence="11 23 25 26 28 29 30">
    <location>
      <position position="457"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_045622" description="In isoform 2." evidence="21">
    <original>MDVENEQILNVNPAD</original>
    <variation>MTKY</variation>
    <location>
      <begin position="1"/>
      <end position="15"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_028901" description="In dbSNP:rs7081726." evidence="9 10 18 19 20 28">
    <original>I</original>
    <variation>V</variation>
    <location>
      <position position="36"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_028902" description="In dbSNP:rs11548765." evidence="10">
    <original>S</original>
    <variation>Y</variation>
    <location>
      <position position="48"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_036375" description="In a breast cancer sample; somatic mutation." evidence="13">
    <original>G</original>
    <variation>R</variation>
    <location>
      <position position="120"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of phosphorylation site. Reduces interaction with BTRC. Abolishes phosphorylation by PKB; when associated with A-457." evidence="11 14">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with BTRC. Strongly reduced ubiquitination." evidence="14">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="71"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with BTRC. Strongly reduced ubiquitination." evidence="14">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="76"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity." evidence="16">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="174"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="16">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="210"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced interaction with EIF4A1." evidence="16">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="16">
    <original>L</original>
    <variation>A</variation>
    <location>
      <position position="252"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity." evidence="16 17">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="253"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation." evidence="16">
    <original>P</original>
    <variation>A</variation>
    <location>
      <position position="255"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-340." evidence="17">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="333"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation." evidence="17">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="337"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on inhibition of EIF4A1 and on inhibition of translation; when associated with A-333." evidence="17">
    <original>L</original>
    <variation>A</variation>
    <location>
      <position position="340"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1." evidence="16">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="358"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation." evidence="17">
    <original>F</original>
    <variation>A</variation>
    <location>
      <position position="359"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation." evidence="17">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="361"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="16">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="414"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="16">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation." evidence="16">
    <original>P</original>
    <variation>A</variation>
    <location>
      <position position="420"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of phosphorylation site, and loss of nuclear accumulation. Abolishes phosphorylation by PKB; when associated with A-67." evidence="11">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="457"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAB42218." evidence="22" ref="1">
    <original>D</original>
    <variation>E</variation>
    <location>
      <position position="79"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB67706." evidence="22" ref="2">
    <original>R</original>
    <variation>G</variation>
    <location>
      <position position="102"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB67706." evidence="22" ref="2">
    <original>V</original>
    <variation>G</variation>
    <location>
      <position position="130"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAB42218." evidence="22" ref="1">
    <original>S</original>
    <variation>T</variation>
    <location>
      <position position="220"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB67706." evidence="22" ref="2">
    <original>L</original>
    <variation>F</variation>
    <location>
      <position position="222"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; BAG37701." evidence="22" ref="3">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="309"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; BAG37701." evidence="22" ref="3">
    <original>V</original>
    <variation>A</variation>
    <location>
      <position position="314"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB67706." evidence="22" ref="2">
    <original>S</original>
    <variation>W</variation>
    <location>
      <position position="440"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="161"/>
      <end position="178"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="181"/>
      <end position="191"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="195"/>
      <end position="198"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="199"/>
      <end position="209"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="213"/>
      <end position="226"/>
    </location>
  </feature>
  <feature type="turn" evidence="33">
    <location>
      <begin position="227"/>
      <end position="229"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="233"/>
      <end position="253"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="257"/>
      <end position="270"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="278"/>
      <end position="281"/>
    </location>
  </feature>
  <feature type="turn" evidence="33">
    <location>
      <begin position="282"/>
      <end position="284"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="289"/>
      <end position="303"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="308"/>
      <end position="313"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="324"/>
      <end position="341"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="344"/>
      <end position="354"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="357"/>
      <end position="359"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="360"/>
      <end position="372"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="378"/>
      <end position="393"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="398"/>
      <end position="418"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="422"/>
      <end position="435"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="441"/>
      <end position="445"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1"/>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="Q61823"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="3">
    <source>
      <dbReference type="UniProtKB" id="Q9JID1"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4"/>
  <evidence type="ECO:0000255" key="5">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00698"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="6">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="10632927"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="12898601"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="16357133"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="16449643"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="16959974"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="17053147"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="18296639"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="19153607"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="19204291"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="9759869"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source ref="1"/>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0000303" key="21">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="22"/>
  <evidence type="ECO:0007744" key="23">
    <source>
      <dbReference type="PubMed" id="15144186"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PubMed" id="15592455"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PubMed" id="16964243"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PubMed" id="17081983"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="32">
    <source>
      <dbReference type="PDB" id="2KZT"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="33">
    <source>
      <dbReference type="PDB" id="2RG8"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="34">
    <source>
      <dbReference type="PDB" id="2ZU6"/>
    </source>
  </evidence>
  <sequence length="469" mass="51735" checksum="2CAE1D2055491177" modified="2011-01-11" version="2">MDVENEQILNVNPADPDNLSDSLFSGDEENAGTEEIKNEINGNWISASSINEARINAKAKRRLRKNSSRDSGRGDSVSDSGSDALRSGLTVPTSPKGRLLDRRSRSGKGRGLPKKGGAGGKGVWGTPGQVYDVEEVDVKDPNYDDDQENCVYETVVLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGVPVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKEIDMLLKEYLLSGDISEAEHCLKELEVPHFHHELVYEAIIMVLESTGESTFKMILDLLKSLWKSSTITVDQMKRGYERIYNEIPDINLDVPHSYSVLERFVEECFQAGIISKQLRDLCPSRGRKRFVSEGDGGRLKPESY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>